SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-14-068828
Filing Date
2014-11-14
Accepted
2014-11-14 16:05:16
Documents
1
Period of Report
2014-11-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4301
  Complete submission text file 0001209191-14-068828.txt   6725
Mailing Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET - LEGAL DEPARTMENT LONDON X0 W2 6BD 011 44 20 7304 5000
ASTRAZENECA PLC (Reporting) CIK: 0000901832 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 141224017
SIC: 2834 Pharmaceutical Preparations

Mailing Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85
Business Address V?STRA M?LAREHAMNEN 9 S?DERT?LJE V7 SE-151 85 0044 (0) 20 7604 800
ASTRAZENECA AB (Reporting) CIK: 0000928966 (see all company filings)

State of Incorp.: NY | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-35670 | Film No.: 141224016

Mailing Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Issuer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations